Targeting Vesicle Trafficking: An Important Approach to Cancer Chemotherapy
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
3
Page:
137-147
Author(s):
Paul K. Wright
Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
Journal:
Current Molecular Pharmacology
Volume:
1
Page:
93-105
Author(s):
Chung-Pu Wu, Anna Maria Calcagno and Suresh V. Ambudkar
Molecular Targeted Agents Combined with Chemo-Radiation in the Treatment of Locally Advanced Cervix Cancer
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
111-120
Author(s):
F. G. Herrera, L. Vidal, A. Oza, M. Milosevic and A. Fyles
Arginine Deprivation as a Targeted Therapy for Cancer
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1049-1057
Author(s):
L. Feun, M. You, C. J. Wu, M. T. Kuo, M. Wangpaichitr, S. Spector and N. Savaraj
Immunotherapy of HCC
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
31-39
Author(s):
Tim F. Greten, Michael P. Manns and Firouzeh Korangy
Molecular and Cellular Regulators of Cancer Angiogenesis
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
743-758
Author(s):
P. P. Goh, D. M. Sze and B. D. Roufogalis
Editorial [Hot Topic:Resent and Future Therapies for the Hepatocellular Carcinoma (Executive Editor: G. Giannelli)]
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3264-3264
Author(s):
G. Giannelli
The Development of Targeted Therapies for Hepatocellular Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3292-3300
Author(s):
D. Chattopadhyay, D. M. Manas and H. L. Reeves
Tyrosine Kinase Inhibitors: A Potential Approach to the Treatment of Hepatocellular Carcinoma
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3301-3304
Author(s):
G. Giannelli, N. Napoli and S. Antonaci
Rationale for New Drugs Targeting the Tissue Microenvironment in Patients with HCC
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3288-3291
Author(s):
S. Antonaci and G. Giannelli